[Current data on ocular toxoplasmosis: management].
D003165:Complement System Proteins / Q000032:analysis; D004395:Dye Dilution Technique; D006801:Humans; D007933:Leucomycins / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D014122:Toxoplasma / Q000276:immunology; D014126:Toxoplasmosis, Ocular / Q000175:diagnosis / Q000188:drug therapy
D007933:Leucomycins; D003165:Complement System Proteins; D011739:Pyrimethamine
Données nouvelles sur la toxoplasmose oculaire; conduit à tenir.